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and multiple regional events—a broad, purpose ful, and 
critical outreach eﬀ ort.
The launches in London and Boston were just that; 
the beginning of an education and advocacy campaign 
intended to highlight the pivotal role of surgical care in 
health system strengthening. The formal Commission 
report,1 32 000 words of synthesis, analysis, recom-
mendations, and indicators, is only one part of the initial 
Commission product. A dozen open-access business-
style teaching cases have been published to provide an 
educational framework focused on global surgery topics. 
In addition, 61 abstracts were presented at the London 
launch and published in The Lancet, and numerous 
full-length articles are being published in The Lancet, 
The Lancet Global Health, World Journal of Surgery, British 
Journal of Surgery, and Surgery. This is the greatest volume 
of academic content published in a synchronised fashion 
in collaboration with ﬁ ve independent journals ever seen 
in the surgical community.
The Lancet Global Health is publishing a special issue 
of Comments, Correspondence, and original research 
Articles linked to The Lancet Commission on Global 
Surgery. Presenting work from all over the world, this 
commitment highlights the importance of international 
collaboration in combating “surgical marginalisation” in 
public health, and supports the themes and vision of the 
Commission.
So if this is our ﬁ rst step, how do we maintain forward 
progress? Delivery of surgery and anaesthesia care 
must be included by care providers, policy makers, 
and funders as a central component of wider health 
system strengthening eﬀ orts. A focus on equitable and 
high-quality care delivery must go hand in hand with a 
commitment to ﬁ nancial risk protection to best care for 
those aﬄ  icted by surgical conditions. And successful 
change must be locally driven by local leaders, supported 
by global partners through true accompaniment, 
global collaboration, and an emphasis on systems, not 
silos. Only in this way will we be able to achieve health, 
welfare, and economic development for all.
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 Tracking global expenditures on surgery: gaps in knowledge 
hinder progress
Very little is known about how much is spent on 
surgical care delivery globally. Anecdotal evidence 
suggests that per-person expenditure on surgery 
varies enormously across countries. This cross-country 
and intervention-speciﬁ c variation makes estimating 
global and country-level expenditure on surgery 
challenging; thus, these expenditure ﬁ gures have not 
been produced to date. This gap in knowledge about 
funding to surgery is a major barrier to scale-up of 
surgical services, because it means that policymakers 
are unaware of the potential growth in expenditure 
associated with changes in care.
In an attempt to estimate global surgical expenditure, 
we reviewed 958 country-generated National Health 
Accounts (NHAs) from 1996 to 2010.1 NHA reports, 
completed annually by high-income countries and 
somewhat routinely by many low-income and middle-
income countries, provide an accounting framework for 
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national expenditure on health. They are the seminal 
tool for systematically tracking and comparing health 
expenditures.2 We found that only two countries, 
Georgia and Kyrgyzstan, have routinely reported 
expenditure on surgery in their NHAs. For the remaining 
countries, we know of no other comparable source for 
tracking funds for surgery. 
We also reviewed the Institute for Health Metrics 
and Evaluation’s (IHME’s) database on development 
assistance for health (DAH).3 DAH, at upwards of 50% 
of government health budgets in some low-income 
countries, can be an important means of ﬁ nancing 
health care.4 Because no major donor or project-level 
database identiﬁ es projects related to surgery, we 
searched the IHME project-level database for projects 
that are described using keywords related to surgery—
ie, “surgery”, “surgeon”, and “operating room”, in-
cluding translations of these keywords into other 
languages used in the database. Correct identiﬁ cation, 
of course, depends on donors describing surgery-
related projects with these precise terms. Nonetheless, 
we found that, in 2011, a total of just US$22 million 
was channelled from high-income countries to low-
income and middle-income countries with the explicit 
purpose of supporting surgery; this is less than 1% of the 
US$30·6 billion of total DAH in 2011. 
Expenditure tracking is essential for strategic rather 
than incremental planning.5 Knowing how much is spent 
on health interventions, including surgery, allows policy-
makers, managers, and donors to assess the allocation of 
resources and identify gaps in ﬁ nancing that could have 
implications for coverage of vital health services. Accessing 
this information will become increasingly important as 
the need for these procedures grows with the anticipated 
increase in burden related to non-communicable diseases 
and injuries in developing countries.6 Retrospective 
estimates of surgery expenditure, paired with burden, can 
feed into projections of the ﬁ nancing needed to deliver 
these services. Such information would allow decision-
makers to eﬃ  ciently manage resources, weighing crucial 
trade-oﬀ s and capitalising on important health-sector 
synergies. Disaggregating spending by types of surgery 
could also expose important areas of expenditure that 
could be reduced with health promotion and prevention 
activities. Overall, basic expenditure data allow for major 
improvements in the management and coordination of 
resources.
Expenditure tracking highlights key ﬁ nancing gaps 
and shortfalls in funding in other areas of health and 
identiﬁ es whether resources are delivered as intended. 
For example, infectious diseases (HIV/AIDS, tuberculosis, 
and malaria) and maternal, newborn, and child health 
programmes have beneﬁ ted from impressive increases 
in DAH commitments.3 Still, such commitments could 
go unrealised, merely replace domestic funding, or be 
wasted away ineﬃ  ciently. Simultaneous investments 
in expenditure tracking mechanisms, such as NHA 
disease-speciﬁ c subaccounts, UNAIDS National AIDS 
Spending Assessments, and the Partnership for Maternal, 
Newborn, and Child Health annual reports, have 
increased the likelihood that these new resources do not 
meet this fate, and are realised as additional to domestic 
expenditure.7–9 Furthermore, tracking methods such as 
these have catalysed action in other sectors, including 
coalitions harnessing pooled resources, expertise, and 
political will for international action.10 
Important strategic decisions must be made to 
accelerate the scale-up of surgical services in low-
resource settings. Robust estimates of the currently 
available ﬁ nancial resources and funding gaps are the 
cornerstones of decision-making. Yet at the most basic 
level, we are unaware of how much is spent on surgical 
care delivery at the country and global levels. We ﬁ nd 
there is very little systematic tracking of expenditure 
on surgery in NHAs, and development assistance for 
surgery appears to be minimal. At a minimum, NHA 
reports should disaggregate health spending to track 
expenditure on surgery and development partners 
should code health projects to identify development 
assistance related to surgery. A robust accounting 
framework that disaggregates health expenditure by 
intervention, such as surgery, is a necessary input for 
systematic and eﬃ  cient scale-up of such a crucial set of 
health interventions.
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The blood drought in context
Universal access to safe, aﬀ ordable surgery when 
needed depends on a suﬃ  cient and safe blood supply. 
This is not the case in most of the world today. The 
average donation rate in low-income countries 
(2·8 donations per 1000 population) is an order of 
magnitude below that of high-income countries 
(36·4 donations per 1000 population).1 To put these 
ﬁ gures into context, take Ethiopia, which has a blood 
donation rate of 0·6 units per 1000 population 
or roughly 56 000 units per year.2 With just over 
3 million births per year in Ethiopia, we know that 
between 66 000 and 230 000 mothers will require 
a blood transfusion for postpartum haemorrhage.3 
In the high-income setting, the median transfusion 
requirement per case of postpartum haemorrhage is 
three units.4 In addition to far exceeding the existing 
blood supply, this leaves nothing for patients with 
other surgical conditions, trauma, and severe malarial 
or sickle-cell anaemia.5
To make the situation even worse, these low donation 
rates are almost certainly overestimates; they include 
blood that is unsafe for use, infected with organisms 
that cause transfusion-transmissible infections (TTIs) 
such as AIDS, hepatitis, malaria, and syphilis.6 In fact, up 
to 52% of blood collected in Nigeria and 14% of blood 
collected in Mali could be contaminated with malarial 
parasites and hepatitis B virus, respectively.7,8 19% of 
blood collected in sub-Saharan Africa is not even tested 
for hepatitis C virus.2 
In Ethiopia and beyond, patients and providers 
have few options when in need of a transfusion. 
One possibility is unbanked direct blood transfusion 
(UDBT), which involves on-the-spot donation from 
a family member or volunteer in the community, a 
screen for TTIs with a rapid testing kit, and a blood 
type cross-match. UDBT is not ideal: rapid testing 
kits are not as sensitive as banked blood screening 
protocols, family and replacement donor blood has a 
higher prevalence of TTIs, and the potential for coerced 
donation is high.6,7 Another option is commercial 
blood donation, whereby eligible individuals are paid 
for donation. Unfortunately, in the setting of poverty, 
payment creates perverse incentives for donation of 
unsafe quantities at unsafe intervals. Reports exist 
of commercial donors presenting to hospitals in 
hypovolaemic shock.8 
However, when faced with the untenable option: 
forego a life-saving operation owing to lack of blood, 
or operate knowing the patient will die with out a 
transfusion, UDBT or commercial donations become 
necessary choices. The dependence on UDBT and 
com mercial blood donors will exist as long as reason-
able alternatives do not. Rather than disregarding or 
banning these practices, practical interim measures 
should be implemented to optimise their safety.8 
Oﬀ ering formal training for providers, developing 
best practices and formal auditing mechanisms, and 
ensuring reliable provision of testing kits can be crucial 
to keeping patients, donors, and providers safe.
Interim measures, however, are not nearly enough. A 
massive expansion of the blood donor pool is needed, 
but scaling up blood donation in the low-resource 
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